News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mates Sharon
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
4/A
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 86,003 options to buy
@ $53.63, valued at
$4.6M
|
|
| 03/13/2023 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 41,770 shares
@ $0
Sold 34,965 shares
@ $43.28, valued at
$1.5M
Sold 6,805 shares
@ $42.51, valued at
$289.3k
Sold 19,153 shares
@ $45.06, valued at
$863k
Sold 1,412 shares
@ $44.08, valued at
$62.2k
Exercised 20,565 restricted stock units
@ $0
Exercised 20,000 options to buy
@ $3.26, valued at
$65.2k
|
|
| 03/08/2023 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 122,137 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 22,590 shares
@ $47.03, valued at
$1.1M
Exercised 22,590 restricted stock units
@ $0
Exercised 30,000 options to buy
@ $3.26, valued at
$97.8k
|
|
| 02/22/2023 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 22,895 shares
@ $46.54, valued at
$1.1M
Sold 2,200 shares
@ $47.35, valued at
$104.2k
Sold 2,502 shares
@ $48.7, valued at
$121.8k
Sold 251 shares
@ $49.6, valued at
$12.4k
Exercised 27,848 restricted stock units
@ $0 |
|
| 12/15/2022 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 33,083 shares
@ $55, valued at
$1.8M
|
|
| 03/14/2022 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 50,167 options to buy
@ $56.73, valued at
$2.8M
Granted 61,696 restricted stock units
@ $0 |
|
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 15,180 shares
@ $55.73, valued at
$846k
Sold 12,667 shares
@ $54.98, valued at
$696.4k
Exercised 27,847 restricted stock units
@ $0 |
|
| 01/11/2022 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 5,804 shares
@ $41.72, valued at
$242.1k
Sold 27,138 shares
@ $40.8, valued at
$1.1M
Sold 8,954 shares
@ $40.1, valued at
$359.1k
Exercised 41,896 restricted stock units
@ $0 |
|
| 10/18/2021 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 1,416 shares
@ $40, valued at
$56.6k
Sold 40,392 shares
@ $40, valued at
$1.6M
Sold 8,192 shares
@ $40, valued at
$327.7k
Exercised 1,075 options to buy
@ $2.84, valued at
$3.1k
|
|
| 08/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Exercised 34,000 options to buy
@ $2.74, valued at
$93.2k
|
|
| 11/12/2020 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 30,869 shares
@ $25.99, valued at
$802.3k
Sold 19,131 shares
@ $26.91, valued at
$514.8k
|
|
| 11/06/2020 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 50,000 shares
@ $25, valued at
$1.3M
|
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2020 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 18,008 shares
@ $0
Disposed of 9,323 shares
@ $23.61, valued at
$220.1k
|
|
| 01/10/2020 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 41,895 shares
@ $26.16, valued at
$1.1M
|
|
| 01/08/2020 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 7,939 shares
@ $29.78, valued at
$236.4k
Sold 37,659 shares
@ $30.39, valued at
$1.1M
Exercised 41,895 restricted stock units
@ $0
Exercised 44,000 options to buy
@ $2.74, valued at
$120.6k
Exercised 16,000 options to buy
@ $2.74, valued at
$43.8k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2019 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 38,059 shares
@ $11.38, valued at
$433.1k
Sold 7,539 shares
@ $11.82, valued at
$89.1k
Sold 6,604 shares
@ $12.43, valued at
$82.1k
Exercised 6,604 restricted stock units
@ $0
Granted 172,697 options to buy
@ $12.73, valued at
$2.2M
Granted 125,687 restricted stock units
@ $0 |
|
| 01/03/2019 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 17,478 shares
@ $0
Sold 17,478 shares
@ $11.09, valued at
$193.8k
Exercised 11,258 restricted stock units
@ $0
Exercised 34,340 restricted stock units
@ $0 |
|
| 12/11/2018 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Exercised 50,000 options to buy
@ $1.5, valued at
$75k
|
|
| 01/10/2018 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 6,604 shares
@ $17.48, valued at
$115.4k
|
|
| 01/05/2018 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 11,257 shares
@ $17.08, valued at
$192.3k
Exercised 11,257 restricted stock units
@ $0
Exercised 6,604 restricted stock units
@ $0
Granted 138,473 options to buy
@ $15.47, valued at
$2.1M
Granted 103,021 restricted stock units
@ $0 |
|
| 11/01/2017 |
4
| Mates Sharon (Chairman, President & CEO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 18,750 shares
@ $15.75, valued at
$295.3k
Exercised 18,750 options to buy
@ $1.5, valued at
$28.1k
|
|
| 01/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|